Cargando…

Triglyceride-glucose index in the prediction of clinical outcomes after successful recanalization for coronary chronic total occlusions

BACKGROUND: Triglyceride-glucose index (TyG) has been widely used to predict cardiovascular outcomes. However, it remains unclear whether TyG holds prognostic significance for patients with coronary chronic total occlusions (CTO). Thus, our study aimed to evaluate the predictive accuracy and prognos...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yu, Ma, Mengqing, Zhang, Jian, Jin, Shiyu, Zhang, Dingxin, Lin, Xianhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634094/
https://www.ncbi.nlm.nih.gov/pubmed/37940976
http://dx.doi.org/10.1186/s12933-023-02037-6
_version_ 1785132757576318976
author Yang, Yu
Ma, Mengqing
Zhang, Jian
Jin, Shiyu
Zhang, Dingxin
Lin, Xianhe
author_facet Yang, Yu
Ma, Mengqing
Zhang, Jian
Jin, Shiyu
Zhang, Dingxin
Lin, Xianhe
author_sort Yang, Yu
collection PubMed
description BACKGROUND: Triglyceride-glucose index (TyG) has been widely used to predict cardiovascular outcomes. However, it remains unclear whether TyG holds prognostic significance for patients with coronary chronic total occlusions (CTO). Thus, our study aimed to evaluate the predictive accuracy and prognostic value of TyG in individuals who underwent successful percutaneous coronary intervention (PCI) for CTO. METHODS: A total of 331 consecutive patients with ≥ 1 successful CTO-PCI were included. The baseline and angiographic data were acquired. The duration of follow-up ranged from 32 to 79 months, with a median of 44 months and an interquartile range of 39 to 67 months. The primary outcome measured was the occurrence of major adverse cardiac and cerebrovascular events (MACCE), including mortality, target vessel revascularization, recurrent myocardial infarction, and stroke. RESULTS: After controlling for confounders, multivariate Cox regression analysis revealed that TyG remained statistically significant, regardless of being a continuous or categorical variable. In the partially adjusted regression model, the Hazard ratio (95%CI) for MACCE was 2.54 (1.12–5.79) in tertile 3 and 1.61 (1.22–2.12) per SD increase in the TyG.Kaplan-Meier survival analysis demonstrated significant differences in MACCE-free survival rates across tertiles of the TyG, as indicated by the log-rank test (p = 0.001). ROC analysis was conducted to evaluate the predictive ability of TyG for MACCE, resulting in an AUC of 0.677. CONCLUSION: The TyG index demonstrates independent predictive capabilities for MACCE in patients who have undergone successful CTO-PCI. These findings suggest that TyG holds the potential as a valuable tool in risk stratification and the identification of patients who may benefit from early intervention in the management of CTO. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12933-023-02037-6.
format Online
Article
Text
id pubmed-10634094
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-106340942023-11-10 Triglyceride-glucose index in the prediction of clinical outcomes after successful recanalization for coronary chronic total occlusions Yang, Yu Ma, Mengqing Zhang, Jian Jin, Shiyu Zhang, Dingxin Lin, Xianhe Cardiovasc Diabetol Research BACKGROUND: Triglyceride-glucose index (TyG) has been widely used to predict cardiovascular outcomes. However, it remains unclear whether TyG holds prognostic significance for patients with coronary chronic total occlusions (CTO). Thus, our study aimed to evaluate the predictive accuracy and prognostic value of TyG in individuals who underwent successful percutaneous coronary intervention (PCI) for CTO. METHODS: A total of 331 consecutive patients with ≥ 1 successful CTO-PCI were included. The baseline and angiographic data were acquired. The duration of follow-up ranged from 32 to 79 months, with a median of 44 months and an interquartile range of 39 to 67 months. The primary outcome measured was the occurrence of major adverse cardiac and cerebrovascular events (MACCE), including mortality, target vessel revascularization, recurrent myocardial infarction, and stroke. RESULTS: After controlling for confounders, multivariate Cox regression analysis revealed that TyG remained statistically significant, regardless of being a continuous or categorical variable. In the partially adjusted regression model, the Hazard ratio (95%CI) for MACCE was 2.54 (1.12–5.79) in tertile 3 and 1.61 (1.22–2.12) per SD increase in the TyG.Kaplan-Meier survival analysis demonstrated significant differences in MACCE-free survival rates across tertiles of the TyG, as indicated by the log-rank test (p = 0.001). ROC analysis was conducted to evaluate the predictive ability of TyG for MACCE, resulting in an AUC of 0.677. CONCLUSION: The TyG index demonstrates independent predictive capabilities for MACCE in patients who have undergone successful CTO-PCI. These findings suggest that TyG holds the potential as a valuable tool in risk stratification and the identification of patients who may benefit from early intervention in the management of CTO. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12933-023-02037-6. BioMed Central 2023-11-08 /pmc/articles/PMC10634094/ /pubmed/37940976 http://dx.doi.org/10.1186/s12933-023-02037-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Yang, Yu
Ma, Mengqing
Zhang, Jian
Jin, Shiyu
Zhang, Dingxin
Lin, Xianhe
Triglyceride-glucose index in the prediction of clinical outcomes after successful recanalization for coronary chronic total occlusions
title Triglyceride-glucose index in the prediction of clinical outcomes after successful recanalization for coronary chronic total occlusions
title_full Triglyceride-glucose index in the prediction of clinical outcomes after successful recanalization for coronary chronic total occlusions
title_fullStr Triglyceride-glucose index in the prediction of clinical outcomes after successful recanalization for coronary chronic total occlusions
title_full_unstemmed Triglyceride-glucose index in the prediction of clinical outcomes after successful recanalization for coronary chronic total occlusions
title_short Triglyceride-glucose index in the prediction of clinical outcomes after successful recanalization for coronary chronic total occlusions
title_sort triglyceride-glucose index in the prediction of clinical outcomes after successful recanalization for coronary chronic total occlusions
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634094/
https://www.ncbi.nlm.nih.gov/pubmed/37940976
http://dx.doi.org/10.1186/s12933-023-02037-6
work_keys_str_mv AT yangyu triglycerideglucoseindexinthepredictionofclinicaloutcomesaftersuccessfulrecanalizationforcoronarychronictotalocclusions
AT mamengqing triglycerideglucoseindexinthepredictionofclinicaloutcomesaftersuccessfulrecanalizationforcoronarychronictotalocclusions
AT zhangjian triglycerideglucoseindexinthepredictionofclinicaloutcomesaftersuccessfulrecanalizationforcoronarychronictotalocclusions
AT jinshiyu triglycerideglucoseindexinthepredictionofclinicaloutcomesaftersuccessfulrecanalizationforcoronarychronictotalocclusions
AT zhangdingxin triglycerideglucoseindexinthepredictionofclinicaloutcomesaftersuccessfulrecanalizationforcoronarychronictotalocclusions
AT linxianhe triglycerideglucoseindexinthepredictionofclinicaloutcomesaftersuccessfulrecanalizationforcoronarychronictotalocclusions